The Latest Breaking News from FDA

Reata CEO Warren Huff says Friedreich's ataxia is "the worst disease." Now, RETA stock investors are watching the long-awaited drug launch.

President Joe Biden’s youngest brother said in a radio interview that the president has been “very open-minded” in conversations the two have had about the benefits of psychedelics as a form of medical treatment

Reata Pharmaceuticals won the FDA's blessing to launch its Friedreich's ataxia drug, and RETA stock surged Wednesday.

When the FDA first asserted the authority to regulate e-cigarettes in 2016, many people assumed the agency would quickly get rid of vapes with flavors like cotton candy, gummy bears, and Froot Loops that appeal to kids.

The Food and Drug Administration rejected a high-dose version of Regeneron's eye drug Eylea on Tuesday, leading REGN stock to crumble.

Five years ago, a Consumer Reports study revealed the presence of toxic metals in several baby food products. Many of those foods still contain hazardous contaminants, a new study found

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

EDITORS/NEWS DIRECTORS:

Brain-chip startup Neuralink announces plans to implant device in tetraplegic or paraplegic patient during livestream

The number of electronic cigarette devices sold in the U.S. has nearly tripled to over 9,000, despite a three-year effort by the Food and Drug Administration to crack down on kid-friendly flavors

LEXINGTON, Ky. -- Jessica Blackburn didn’t know she was addicted to opioids until her body’s first withdrawal.